Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia

BACKGROUND: Apixaban, an oral anticoagulant for stroke and systemic embolism prevention in non-valvular atrial fibrillation (NVAF), was superior to warfarin in prevention of stroke and systemic embolism, bleeding outcomes and mortality (ARISTOTLE trial), and substantially reduced stroke risk, with n...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Saudi Med
Main Authors: Hersi, Ahmad S., Osenenko, Katherine M., Kherraf, Sid Ahmed, Aziz, Ayman Abdel, Sambrook, Robert Joseph
Formato: Artigo
Idioma:Inglês
Publicado em: King Faisal Specialist Hospital and Research Centre 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6838647/
https://ncbi.nlm.nih.gov/pubmed/31381381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5144/0256-4947.2019.265
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados